Work

A phase II study of live-attenuated Listeria monocytogenes immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps3121

Authors: Warner King Huh, William E. Brady, Kathleen N. Moore, Heather A. Lankes, Bradley J. Monk, Carol Aghajanian, Don S. Dizon, Paula M. Fracasso

Institutions: University of Alabama at Birmingham, University of Oklahoma Health Sciences Center, Gynecologic Oncology Group, Creighton University, St. Joseph's Hospital and Medical Center, Memorial Sloan Kettering Cancer Center, Women & Infants Hospital of Rhode Island, University of Virginia

Language: English

Topic: Cancer Research and Treatments

Subfield: Biotechnology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4252290668

Cites:

Cited by: 1

Related to: 10